Companies: 10,795·Total market cap: $144.5T
ChromoCure, Inc.

ChromoCure, Inc.

KKUROTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$8200
P/E Ratio
52W High$0.000002
52W Low$0.000001
Overview

ChromoCure, Inc. (KKUR) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

kkur · market cap & enterprise value · FMP · as of Jan 12, 2026

Core market cap & key metrics

As of Jan 12, 2026, ChromoCure, Inc. (KKUR) has a market cap — also referred to as its net worth or valuation — of $8,200, making it one of the top most valuable companies globally. Market Cap = $0.00 × shares outstanding.

Market Cap (Net Worth)$8,200kkur market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0kkur highest market cap ever
Stock Price$0.00OTC · Jan 12, 2026
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

ChromoCure, Inc. (KKUR) has a market cap — also referred to as its net worth or valuation — of $8,200 as of Jan 12, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

ChromoCure, Inc. reached its all-time high market cap of $0 on —. Comparing the ChromoCure, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare ChromoCure, Inc. net worth vs peers and ask how ChromoCure, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

KKUR market cap · 6 questions

ChromoCure, Inc.'s net worth — measured as market capitalization — is $8,200 as of Jan 12, 2026. It ranks #0 globally. Market Cap = $$0.00 (price) × shares outstanding.

KKUR net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.